Tyk Medicines

Developer of drugs for the treatment of cancer

placeXuhui, Shanghai, China calendar_todayFounded 2018 groups100 employees language tykmedicines.com

Investor mix

13 investors on record; lead investors include Guohai Innovation Capital Investment Management, Huge Capital, Sichuan Huiyu Pharmaceutical, Yida China Holdings.

Investor typeCountShare
Venture capital215%
Private equity431%
Bank & private debt18%
Other / undisclosed646%
Coming soon